Lateral Epicondylitis (Tennis Elbow)

1. Clinical Overview

Summary

Lateral epicondylitis, commonly known as "tennis elbow," is a degenerative tendinopathy affecting the common extensor origin at the lateral epicondyle of the humerus, most commonly involving the extensor carpi radialis brevis (ECRB) tendon. Despite its eponymous association with tennis, only 5-10% of cases occur in tennis players, with the majority affecting individuals engaged in repetitive gripping, twisting, or forceful activities in occupational or recreational settings. [1,2]

The condition is characterized by insidious onset of lateral elbow pain exacerbated by resisted wrist extension, gripping activities, and forearm supination. The underlying pathology is angiofibroblastic degeneration rather than acute inflammation, explaining the limited efficacy of anti-inflammatory interventions and the rationale for load-based rehabilitation strategies. [3]

Lateral epicondylitis is predominantly a self-limiting condition, with 80-90% of cases resolving within 12-18 months regardless of intervention. [4] Conservative management remains first-line, with eccentric exercise-based physiotherapy demonstrating superior outcomes to passive treatments. Corticosteroid injections, while providing short-term symptomatic relief (4-6 weeks), have been associated with worse long-term outcomes and higher recurrence rates compared to watchful waiting or physiotherapy. [5,6] Surgical intervention is reserved for the 5-10% of refractory cases failing 12-18 months of conservative treatment.

Key Facts

• Prevalence: 1-3% of general population; 4-7 per 1000 patients in primary care annually [7]
• Peak incidence: 40-50 years of age (35-54 years in most studies) [8]
• Pathology: Angiofibroblastic degeneration of ECRB tendon with absence of inflammatory cells [3,9]
• Classic presentation: Lateral elbow pain worsened by gripping, lifting, and resisted wrist extension
• Diagnosis: Primarily clinical; imaging rarely required
• First-line treatment: Activity modification, physiotherapy (eccentric exercises), counterforce bracing
• Natural history: 80-90% spontaneous resolution within 12-18 months [4]
• Prognosis: Excellent with conservative care; recurrence 8-12% [10]

Clinical Pearls

"Tennis Elbow Without the Tennis": Only 5-10% of lateral epicondylitis cases occur in tennis players. Occupational activities involving repetitive gripping, forceful exertion, or prolonged hand tool use (plumbers, carpenters, painters, computer users) account for the majority of cases. [1,2]

"Tendinopathy, Not Tendinitis": Histopathological studies consistently demonstrate angiofibroblastic degeneration, disorganized collagen (specifically Type III collagen deposition), neovascularization, and notably the ABSENCE of inflammatory cells (no neutrophils, lymphocytes, or macrophages). The term "epicondylitis" is a historical misnomer; "epicondylopathy" or "tendinopathy" is more accurate. This explains why NSAIDs and corticosteroids have limited long-term efficacy. [3,9]

"Steroid Paradox: Short-Term Friend, Long-Term Foe": Multiple randomized controlled trials demonstrate that corticosteroid injections provide significant pain relief at 4-6 weeks but result in worse outcomes at 6-12 months compared to physiotherapy or watchful waiting, with higher recurrence rates (54% vs 12%) and lower cure rates (28% vs 91%). [5,6,11] The mechanism may involve tendon weakening, impaired collagen synthesis, and disruption of normal healing processes.

"Eccentric Loading is Gold Standard": Physiotherapy programs emphasizing eccentric strengthening of wrist extensors (slow, controlled lengthening under load) demonstrate superior outcomes to concentric exercise, passive modalities, or observation alone. The number needed to treat (NNT) is approximately 4 for clinically significant improvement at 12 weeks. [12,13]

"Cozen's Test: High Sensitivity, Low Specificity": Resisted wrist extension with the elbow extended (Cozen's test) has sensitivity of 84-89% but specificity of only 23-48% for lateral epicondylitis. Clinical diagnosis requires correlation of history, provocative maneuvers, and exclusion of differential diagnoses. [14]

---

2. Epidemiology

Incidence & Prevalence

• General population prevalence: 1-3% of adults [7,8]
• Primary care incidence: 4-7 per 1000 patients per year [7]
• Annual incidence: 1.3-3.5 per 1000 population [15]
• Duration: Mean symptom duration at presentation 6-12 months
• Bilateral involvement: 10-20% of cases [2]

Demographics

Risk Factors

Occupational Risk Factors

High-Risk Occupations

• Manual trades: Plumbers, electricians, carpenters, bricklayers, welders
• Food industry: Butchers, chefs, food processing workers
• Construction: Painters, decorators, demolition workers
• Manufacturing: Assembly line workers, packagers, machine operators
• Service industry: Cleaners, hairdressers
• Office workers: Prolonged computer use (controversial; weaker association)
• Gardening/agriculture: Hedge trimmers, pruning, manual harvest

Recreational Risk Factors

Individual Risk Factors

Temporal Patterns

• Symptom onset: Insidious (gradual) in > 90%; acute traumatic onset rare (less than 10%)
• Natural history: Self-limiting; 80-90% resolution by 12-18 months without specific intervention [4]
• Chronicity: 5-10% develop chronic symptoms > 18 months
• Seasonal variation: Increased presentation spring/summer (outdoor activities, gardening)

---

3. Pathophysiology

Anatomical Basis

Common Extensor Origin

The common extensor origin (CEO) is a tendinous confluence attaching to the anterior aspect of the lateral epicondyle of the humerus, comprising five muscles:

Why ECRB is Primarily Affected

The extensor carpi radialis brevis (ECRB) is the most commonly involved tendon (80-90% of cases) due to several anatomical and biomechanical vulnerabilities: [20]

1. Anatomical position: The ECRB origin is located on the deep surface of the CEO, directly apposed to the lateral epicondyle and radiohumeral joint, subjected to repetitive friction and compression against bony surfaces during wrist extension and forearm rotation.

2. Relative hypovascularity: The ECRB tendon possesses a "watershed zone" approximately 2-3 mm from its humeral insertion, an area of relatively poor blood supply predisposing to degenerative changes and impaired healing. [21]

3. Mechanical loading: During gripping and wrist extension (functional position for most manual tasks), the ECRB experiences the highest tensile forces within the CEO complex, estimated at 400-600% of resting length during maximal contraction.

4. Shear forces: Radial deviation combined with pronation generates significant shear forces at the ECRB origin.

5. Lack of protective muscle mass: Unlike the ECRL (which has proximal muscle belly protection), the ECRB tendinous origin is exposed to direct trauma and overload.

Histopathology: Angiofibroblastic Degeneration

The hallmark pathological finding in lateral epicondylitis is angiofibroblastic hyperplasia (also termed angiofibroblastic degeneration or tendinosis), characterized by: [3,9]

Macroscopic Findings

• Thickened, grayish tendon appearance (loss of white, glistening quality)
• Focal areas of softening or friability
• Occasional partial-thickness tears or cleavage within tendon substance
• Increased tendon cross-sectional area (swelling)

Microscopic Findings

Key Point: The term "epicondylitis" (implying inflammation with suffix "-itis") is a misnomer. No inflammatory infiltrate is present. More accurate terms include:

• Lateral epicondylopathy
• Lateral epicondylosis
• ECRB tendinopathy/tendinosis

Pathophysiological Cascade

Stage 1: Repetitive Microtrauma (Weeks to Months)

• Initiating event: Repetitive eccentric contractions (lengthening under load), forceful gripping, or sustained wrist extension
• Cellular response: Tenocyte strain → microtears in collagen fibrils → mechanical disruption
• Load accumulation: Insufficient recovery time between loading cycles → cumulative microtrauma exceeds repair capacity
• Molecular changes: Upregulation of matrix metalloproteinases (MMPs), particularly MMP-1, MMP-3, MMP-13 → collagen degradation exceeds synthesis [23]

Stage 2: Failed Healing Response (Months)

• Repair attempt: Tenocytes attempt to synthesize new collagen (Type III > Type I ratio)
• Disorganized matrix: Random collagen orientation (loss of parallel alignment) → reduced tensile strength
• Vascular ingrowth: Neovascularization (new blood vessel formation) accompanies neural ingrowth → hypersensitivity and pain [22]
• Neuropeptide release: Substance P, calcitonin gene-related peptide (CGRP), glutamate → pain sensitization
• Biomechanical weakness: Structurally incompetent tendon → further injury with continued loading

Stage 3: Chronic Degeneration (> 6-12 Months)

• Tendinosis: Established degenerative pathology with hyaline transformation, mucoid change
• Pain chronification: Central sensitization, altered pain processing
• Functional limitation: Reduced grip strength (20-40% deficit), avoidance behaviors
• Self-perpetuation: Pain → disuse → deconditioning → further weakness → pain cycle

Molecular and Cellular Mechanisms

Biomechanical Considerations

• Load tolerance: Healthy tendon tolerates 4-8% strain; pathological tendon fails at 2-4% strain
• Eccentric loading: Lengthening contractions (e.g., lowering a weight) generate greater force and microtrauma than concentric contractions
• Viscoelastic creep: Repetitive loading without recovery → permanent tendon elongation and structural failure
• Grip strength: Peak ECRB loading occurs at 40-60% maximal grip; moderate gripping tasks most pathological

Why the Condition is Self-Limiting

The 80-90% spontaneous resolution rate at 12-18 months is attributed to: [4]

1. Remodeling: Given sufficient time (12-18 months), collagen remodeling eventually restores partial tendon integrity
2. Reduced loading: Pain-driven activity modification allows natural healing
3. Neuroplasticity: Central pain desensitization over time
4. Vascular maturation: Early neovascularization eventually matures and becomes less pain-sensitive

---

4. Clinical Presentation

Symptoms

Cardinal Symptoms

Symptom Onset and Progression

• Onset: Insidious (gradual) over weeks to months in 90%; acute onset (specific injury) in less than 10%
• Duration at presentation: Mean 6-12 months; many delay seeking care
• Diurnal pattern: Often worse with activity throughout day; may have morning stiffness (mild)
• Night pain: Uncommon (less than 20%); if present, consider alternative diagnosis (arthritis, malignancy)
• Radiation: Pain may radiate distally into extensor forearm (50%); rarely proximal to arm (less than 10%)

Functional Limitations

Patients commonly report difficulty with:

Atypical Presentations

Differential Diagnosis Considerations

Conditions That May Mimic Lateral Epicondylitis

Red Flag Symptoms Requiring Further Investigation

---

5. Clinical Examination

Inspection

Palpation

Key Point: Maximal tenderness in lateral epicondylitis is typically 1 cm distal and anterior to the lateral epicondyle, corresponding to the ECRB origin. This is a critical localizing sign. [14]

Range of Motion (ROM)

Key Point: Lateral epicondylitis typically does NOT restrict elbow ROM. Significant ROM restriction suggests arthritis, post-traumatic stiffness, or intra-articular pathology.

Provocative Tests (Special Tests)

High-Yield Provocative Maneuvers

Interpretation Notes:

• High sensitivity, low specificity: Positive tests support diagnosis but may be positive in other conditions (low specificity)
• Clinical diagnosis: No single test is diagnostic; diagnosis based on constellation of history + examination findings
• Pain provocation is key: The critical finding is reproduction of lateral epicondyle pain, not just discomfort

Tests to Differentiate from Radial Tunnel Syndrome [25]

Key Differentiator: Point of maximal tenderness is the most reliable clinical distinguisher. RTS pain is more distal (mobile wad of Henry). Up to 5% of patients may have overlapping features. [25]

Neurological Examination

Critical Point: Neurological examination should be entirely normal in isolated lateral epicondylitis. Any neurological deficit mandates consideration of nerve compression or cervical radiculopathy.

Cervical Spine Examination (to Exclude Radiculopathy)

Examination Summary

Classic Lateral Epicondylitis Examination Profile:

• Localized tenderness 1 cm distal/anterior to lateral epicondyle
• Positive Cozen's test (pain with resisted wrist extension)
• Positive Mill's test (pain with passive wrist flexion + pronation)
• Reduced grip strength (pain-limited)
• Normal elbow ROM
• Normal neurological examination
• Normal cervical spine examination

Atypical examination findings warrant imaging or specialist referral.

---

6. Investigations

General Principles

• Lateral epicondylitis is a CLINICAL diagnosis in typical presentations
• Imaging is NOT required for diagnosis in straightforward cases
• Imaging indications: Atypical features, failed conservative treatment, pre-operative planning, medicolegal documentation, or to exclude differential diagnoses

Imaging Modalities

Plain Radiography (X-ray)

Indications:

• History of acute trauma (exclude fracture)
• Suspected arthritis (joint space loss, osteophytes, loose bodies)
• Atypical pain pattern
• Failed conservative treatment (exclude occult bony pathology)
• Pre-operative assessment

Views: AP, lateral, radial head view

Findings in Lateral Epicondylitis:

• Usually normal (> 90% of cases)
• Occasionally: soft tissue calcification at lateral epicondyle (10-15%; chronic cases)
• Occasionally: small enthesophyte (bony spur) at lateral epicondyle (chronic traction)

Utility: Low sensitivity/specificity for LE; primarily to exclude other pathology

Findings Suggesting Alternative Diagnosis:

• Joint space narrowing → osteoarthritis
• Radial head fracture or old fracture deformity
• Loose bodies → osteochondritis dissecans, synovial chondromatosis
• Bone lesion → tumor, infection

Ultrasound (US)

Advantages:

• Non-invasive, no radiation
• Dynamic assessment (can assess with movement)
• Operator-dependent
• Good tendon visualization
• Can guide injections

Indications:

• Atypical presentation
• Symptoms > 3-6 months not responding to conservative treatment
• Ruling out full-thickness tear
• Pre-injection planning (if injection considered)

Normal ECRB tendon on US:

• Homogeneous echogenic (bright) fibrillar pattern
• Parallel fibrillar architecture
• Tendon thickness 4-5 mm

Findings in Lateral Epicondylitis: [26]

• Hypoechoic (dark) areas within ECRB tendon (angiofibroblastic degeneration, collagen disruption)
• Increased tendon thickness (> 5.5 mm; swelling, edema)
• Loss of fibrillar pattern (disorganized collagen)
• Neovascularization on Doppler (increased blood flow; correlates with symptoms) [22]
• Intrasubstance tears (clefts, partial thickness defects)
• Full-thickness tears (very rare; less than 2%)
• Cortical irregularity at lateral epicondyle (enthesopathy)
• Calcification (chronic cases)

Grading (Modified Nirschl):

• Grade 0: Normal
• Grade 1: Hypoechoic region less than 25% tendon thickness
• Grade 2: Hypoechoic region 25-50% thickness
• Grade 3: Hypoechoic region > 50% thickness
• Grade 4: Full-thickness tear

Limitations:

• Operator-dependent (requires experienced musculoskeletal sonographer)
• Limited assessment of deep structures, bone marrow
• Asymptomatic tendons may show degenerative changes (low specificity)

Magnetic Resonance Imaging (MRI)

Advantages:

• Excellent soft tissue resolution
• Multiplanar imaging
• Assesses bone marrow, cartilage, ligaments
• Not operator-dependent (unlike US)

Indications:

• Atypical presentation (suspected tumor, infection, occult fracture)
• Diagnostic uncertainty (radial tunnel syndrome, posterolateral rotatory instability)
• Failed conservative treatment (pre-operative planning)
• Elite athletes or high-level performers (detailed assessment)
• Suspected intra-articular pathology

Findings in Lateral Epicondylitis: [26]

• Increased T2/STIR signal in ECRB tendon (edema, degeneration)
• Tendon thickening (> 6 mm)
• Partial-thickness tear (intrasubstance signal abnormality, fiber disruption)
• Full-thickness tear (rare; less than 2%)
• Peritendinous edema (surrounding soft tissue edema)
• Bone marrow edema at lateral epicondyle on STIR/T2 fat-sat (reactive changes)
• Joint effusion (if coexistent arthritis)

Asymptomatic Changes: Up to 10-15% of asymptomatic individuals have ECRB signal changes on MRI → low specificity; must correlate clinically.

Utility: High sensitivity; moderate specificity; primarily reserved for complex or refractory cases.

Electrodiagnostic Studies (EMG/NCS)

Indications:

• Suspected radial tunnel syndrome / posterior interosseous nerve (PIN) entrapment
• Suspected cervical radiculopathy
• Neurological deficit on examination
• Atypical pain pattern with sensory or motor symptoms

Findings:

• Normal in lateral epicondylitis (no neuropathy)
• Abnormal in radial tunnel syndrome: May show denervation of supinator, PIN-innervated muscles (finger extensors, thumb extensors); NCS often normal (PIN is motor branch)
• Abnormal in cervical radiculopathy: Denervation in C6/C7 myotomes; abnormal sensory responses

Utility: To differentiate lateral epicondylitis from neurological causes of lateral elbow pain. [25]

Laboratory Investigations

Generally NOT indicated for isolated lateral epicondylitis.

Indications for Blood Tests:

• Atypical systemic features (fever, malaise, weight loss)
• Multiple joint involvement (polyarthralgia)
• Suspected inflammatory arthritis (rheumatoid arthritis, seronegative spondyloarthropathy)
• Suspected crystal arthropathy (gout, pseudogout)
• Suspected infection

Tests to Consider (if indicated):

• Inflammatory markers: ESR, CRP (elevated in inflammatory arthritis, infection)
• Rheumatoid factor (RF), anti-CCP: Rheumatoid arthritis
• ANA: Connective tissue disease (rare to present as isolated elbow pain)
• Uric acid: Gout (note: normal uric acid does not exclude gout)
• HLA-B27: Seronegative spondyloarthropathy (if axial symptoms)
• Complete blood count: Infection, malignancy

Diagnostic Injection (Optional)

Principle: Local anesthetic (1-2 mL lidocaine) injection into site of maximal tenderness; if pain immediately relieved, confirms lateral epicondyle as pain generator.

Utility:

• Diagnostic uncertainty (differentiating from cervical radiculopathy, radial tunnel syndrome)
• Pre-operative confirmation

Caveat: Does not differentiate lateral epicondylitis from radial tunnel syndrome if injection site overlaps.

Investigation Summary

Typical Lateral Epicondylitis (No Imaging Needed):

• Age 40-50 years
• Insidious onset lateral elbow pain
• Positive Cozen's/Mill's tests
• Tenderness at ECRB origin
• Normal neurovascular examination
• No red flags

Atypical Features Warranting Imaging:

• Age less than 30 or > 60 years
• Acute traumatic onset
• Night pain or pain at rest
• Neurological deficit
• Failed 3-6 months conservative treatment
• Suspected alternative diagnosis

Imaging Algorithm:

1. First-line: Plain X-ray (exclude bony pathology)
2. Second-line: Ultrasound (confirm tendinopathy, assess severity, guide injection)
3. Third-line: MRI (atypical presentation, pre-operative planning, exclude occult pathology)

---

7. Management

General Principles

1. Lateral epicondylitis is self-limiting: 80-90% resolve spontaneously within 12-18 months [4]
2. Conservative treatment is first-line: Activity modification, physiotherapy (eccentric exercises), and bracing are effective and safe
3. Corticosteroid injections are not first-line: Despite short-term benefit (4-6 weeks), they result in worse long-term outcomes and higher recurrence rates [5,6,11]
4. Surgical intervention is rare: Reserved for less than 5-10% of cases failing 12-18 months of conservative treatment
5. Evidence-based interventions: Eccentric exercise and activity modification have the strongest evidence [12,13]

Conservative Management (First-Line)

1. Education and Reassurance

Key Messages:

• Natural history: Self-limiting condition; 80-90% resolve within 12-18 months regardless of specific intervention [4]
• Pathophysiology: Degenerative tendinopathy (not inflammation); healing takes time; repeated microtrauma prevents natural repair
• Activity modification is crucial: Continued aggravating activities prolong symptoms
• Realistic expectations: Improvement is gradual; acute flare-ups may occur; patience required

Evidence: Structured patient education improves adherence to physiotherapy and outcomes. [27]

2. Activity Modification and Ergonomic Assessment

Principles:

• Relative rest (not complete immobilization): Avoid/minimize aggravating activities (heavy lifting, forceful gripping, repetitive wrist extension) while maintaining gentle ROM
• Workplace assessment: Ergonomic modification for occupational cases (tool redesign, task rotation, workstation adjustment)
• Gradual return to activity: Progressive loading as symptoms improve

Occupational Modifications:

• Reduce repetition and force (lighter tools, power-assisted tools)
• Modify grip size (larger diameter reduces load on extensors)
• Task rotation (avoid prolonged single-task repetition)
• Microbreaks (5-minute breaks every 30-60 minutes)

Evidence: Activity modification alone results in 50-60% symptom improvement at 6 months. [27]

3. Physiotherapy: Eccentric Exercise Programs (GOLD STANDARD)

Eccentric exercise (muscle lengthening under load) is the most effective conservative intervention for lateral epicondylitis. [12,13]

Mechanism of Action:

• Promotes collagen remodeling and alignment
• Increases tendon tensile strength
• Disrupts neovascularization (reduces pain)
• Stimulates tenocyte activity and healing
• Improves eccentric strength (functional loading capacity)

Tyler Eccentric Wrist Extensor Protocol (Evidence-Based): [12]

Key Technical Points:

• Eccentric phase only: Affected arm ONLY lowers the weight (slow, controlled); unaffected arm returns to start position
• Pain tolerance: Mild discomfort (≤3/10 pain) is acceptable during exercise; severe pain (> 5/10) → reduce load
• Gradual progression: Increase weight by 0.25-0.5 kg increments weekly as tolerated
• Consistency: Daily adherence is critical; sporadic exercise ineffective

Evidence: NNT = 4 for clinically significant improvement at 12 weeks; superior to concentric exercise, stretching alone, or ultrasound therapy. [12,13]

Other Physiotherapy Modalities:

4. Counterforce Bracing (Forearm Strap)

Mechanism:

• Applied 5 cm distal to lateral epicondyle (over muscle bellies of wrist extensors)
• Disperses load away from ECRB origin
• Alters muscle activation pattern
• Reduces strain on common extensor origin

Evidence: Moderate-quality evidence for short-term pain relief and improved grip strength during activity. [30] Does NOT accelerate healing but facilitates function.

Usage:

• Wear during aggravating activities (work, sports, lifting)
• Remove during rest (avoid continuous use → muscle atrophy)
• Ensure proper fit (snug but not restricting blood flow)

Effectiveness: Symptom reduction 20-30% during use; NO long-term benefit when discontinued. Adjunct, not standalone treatment. [30]

5. Pharmacological Analgesia

Key Point: Because lateral epicondylitis is a degenerative tendinopathy (not inflammatory), NSAIDs address symptoms only, not pathology. Short-term use acceptable; long-term use not supported. [3,9]

Injection Therapies

Corticosteroid Injection (NOT Recommended as First-Line)

Mechanism: Anti-inflammatory and analgesic; reduces pain short-term but may impair collagen synthesis and tendon healing.

Evidence:

• Short-term (4-6 weeks): Significant pain reduction; superior to placebo or physiotherapy at 6 weeks [5,6]
• Medium-term (3-6 months): No difference vs placebo or physiotherapy
• Long-term (12 months): WORSE outcomes than physiotherapy or watchful waiting; lower cure rates (28% vs 91%) and higher recurrence (54% vs 12%) [5,6,11]

Landmark Study - Bisset et al (2006): [5]

• RCT: Corticosteroid injection vs physiotherapy vs wait-and-see
• 6 weeks: Steroid superior (pain relief)
• 52 weeks: Wait-and-see and physiotherapy SUPERIOR to steroid (cure rate 91% vs 28%)
• Conclusion: "Corticosteroid injection shows favorable results in the short term but produces significantly worse outcomes in the long term compared with physiotherapy and wait-and-see approaches." [5]

Adverse Effects:

• Skin atrophy, hypopigmentation (5-10%)
• Subcutaneous fat atrophy
• Tendon weakening (risk of rupture; rare in elbow)
• Transient pain flare (24-48 hours post-injection)
• Hyperglycemia (diabetic patients)

When to Consider (Shared Decision-Making):

• Severe pain refractory to analgesics
• Patient requires short-term functional improvement (specific event, competition)
• Patient informed of long-term risks
• Maximum 2-3 injections lifetime (risk of tendon damage)

Technique:

• 1 mL corticosteroid (triamcinolone 10-20 mg or methylprednisolone 40 mg) + 1 mL lidocaine 1%
• Inject at point of maximal tenderness (ECRB origin, 1 cm distal/anterior to lateral epicondyle)
• Peppering technique (multiple small deposits) or single bolus
• Rest 48 hours post-injection; avoid heavy loading 2 weeks

Current Guideline Recommendations:

• NICE CKS: "Corticosteroid injection is not recommended in view of high recurrence rate and worse long-term outcomes" [27]
• AAOS: "No recommendation for or against corticosteroid injection due to conflicting evidence" (inconclusive)

Platelet-Rich Plasma (PRP) Injection

Mechanism: Autologous blood concentrate enriched with platelets (growth factors: PDGF, TGF-β, VEGF); hypothesized to promote tendon healing and collagen synthesis.

Evidence:

• Systematic reviews: Conflicting results; some show superiority to corticosteroid at 6-12 months; others show no difference vs placebo [31,32]
• Heterogeneity: Variable PRP preparation protocols (platelet concentration, leukocyte inclusion, activation method) limit generalizability
• Peerbooms et al (2010): [33] RCT showing PRP superior to corticosteroid at 1 year (73% vs 51% improvement); NO placebo control
• Meta-analysis (2021): Moderate evidence for benefit vs corticosteroid; insufficient evidence vs placebo [31]

Current Status: Controversial; some evidence of benefit but inconsistent methodology and lack of standardization. Not universally recommended.

Advantages: Autologous (low risk of reaction); no long-term adverse effects Disadvantages: Expensive; not covered by insurance; preparation variability; requires venipuncture; painful injection; 2-3 injections often required

Recommendations:

• Consider in refractory cases (> 6 months failed conservative treatment)
• Inform patient of uncertain evidence and cost
• May be alternative to surgery in patients declining operative intervention

Autologous Blood Injection

Mechanism: Similar to PRP; autologous blood (without centrifugation) provides growth factors.

Evidence: Limited RCTs; some show benefit vs placebo; less evidence than PRP. [34]

Role: Inexpensive alternative to PRP; similar rationale; weak evidence.

Other Injection Therapies (Limited/No Evidence)

Extracorporeal Shockwave Therapy (ESWT)

Mechanism: High-energy acoustic waves applied to tendon; proposed mechanisms include neovascularization disruption, pain fiber desensitization, growth factor release.

Types:

• Radial shockwave (rESWT): Lower energy, superficial
• Focused shockwave (fESWT): Higher energy, targeted depth

Evidence:

• Moderate-quality evidence for benefit in chronic refractory lateral epicondylitis (> 6 months) [29]
• Systematic review (2020): [29] 60-70% improvement vs 30-40% placebo at 3-12 months; effect size moderate
• Optimal protocol: 3-5 sessions, 1 week apart, 2000 shocks per session

Indications:

• Failed 6 months of conservative treatment (physiotherapy, activity modification)
• Patient wishes to avoid injection or surgery
• Alternative to PRP in refractory cases

Adverse Effects: Transient pain, erythema, hematoma (minor); well-tolerated

Recommendation: Consider in refractory cases (> 6 months) as alternative to injection or surgery. Not first-line. [29]

Surgical Management

Indications:

• Failed 12-18 months of comprehensive conservative treatment (physiotherapy, activity modification, bracing, ± injection)
• Significant functional impairment or work disability
• Patient-reported unacceptable quality of life
• MRI/US confirmation of severe tendinopathy or partial tear

Surgical Options:

Open ECRB Debridement (Nirschl Technique): [35]

1. Longitudinal incision centered over lateral epicondyle
2. Split interval between ECRL and EDC
3. Identify and incise capsule
4. Identify ECRB (deep to EDC, anterior to radiocapitellar joint)
5. Excise macroscopically abnormal, grayish, friable tendon tissue (usually 4-8 mm of distal ECRB)
6. Decorticate lateral epicondyle (bone bleeding for healing)
7. Repair ECRB to adjacent healthy tendon or bone anchors
8. Close in layers

Arthroscopic ECRB Release: [35]

• Proximal anteromedial and proximal anterolateral portals
• Identify "bare area" over capitellum (anterior capsule insertion)
• Debride ECRB origin from capsule; release from lateral epicondyle
• Treat intra-articular pathology (synovitis, loose bodies, chondromalacia)
• Lower morbidity; faster return to work (4-6 weeks vs 8-12 weeks open)

Outcomes:

• Success rate: 80-90% good-excellent results (pain relief, return to function) [35]
• Return to work: 6-12 weeks (arthroscopic 4-8 weeks)
• Return to sport: 3-6 months (full recovery 6-12 months)
• Patient satisfaction: 85-90%

Complications:

• Infection (1-2%)
• Nerve injury (posterior interosseous nerve, lateral antebrachial cutaneous nerve; less than 2%)
• Persistent pain (10-20%; may require revision)
• Stiffness (rare with appropriate rehabilitation)
• Recurrence (5-10%)

Rehabilitation Post-Surgery:

• Week 0-2: Rest, ice, gentle ROM (avoid resisted wrist extension)
• Week 2-6: Progressive ROM, gentle isometric strengthening
• Week 6-12: Eccentric strengthening, progressive loading
• Month 3-6: Return to unrestricted activities, sport-specific training

Management Algorithm

┌───────────────────────────────────────────────────────────────────┐
│             LATERAL EPICONDYLITIS MANAGEMENT ALGORITHM             │
├───────────────────────────────────────────────────────────────────┤
│                                                                   │
│  INITIAL PRESENTATION (Acute, less than 6 weeks)                           │
│  ├─ Education (natural history, self-limiting)                    │
│  ├─ Activity modification                                         │
│  ├─ Simple analgesia (paracetamol, topical NSAIDs)                │
│  ├─ Counterforce brace (if needed for function)                   │
│  └─ Reassess 4-6 weeks                                             │
│                                                                   │
│                         ↓                                         │
│                                                                   │
│  SUBACUTE (6 weeks - 3 months)                                    │
│  If persistent symptoms:                                          │
│  ├─ PHYSIOTHERAPY (eccentric exercise program) ← GOLD STANDARD    │
│  ├─ Continue activity modification + brace                        │
│  ├─ Consider workplace ergonomic assessment                       │
│  └─ Reassess 3 months                                             │
│                                                                   │
│                         ↓                                         │
│                                                                   │
│  CHRONIC (3-6 months)                                             │
│  If inadequate response:                                          │
│  ├─ Continue/optimize physiotherapy (compliance check)            │
│  ├─ Consider imaging (US or MRI) to confirm diagnosis             │
│  ├─ Consider ESWT (extracorporeal shockwave therapy)              │
│  ├─ Consider PRP injection (if severe, patient preference)        │
│  ├─ Corticosteroid injection ONLY if severe pain, short-term      │
│  │   relief needed, informed of long-term risks                   │
│  └─ Reassess 3-6 months                                           │
│                                                                   │
│                         ↓                                         │
│                                                                   │
│  REFRACTORY (> 12-18 months)                                       │
│  If failed comprehensive conservative treatment:                  │
│  ├─ Imaging (MRI) to assess severity, exclude other pathology     │
│  ├─ Consider surgical referral (orthopaedics/sports medicine)     │
│  ├─ Options: Open debridement, arthroscopic release               │
│  └─ Success rate: 80-90%                                          │
│                                                                   │
└───────────────────────────────────────────────────────────────────┘

Treatments NOT Recommended (Insufficient Evidence)

---

8. Complications

Complications of the Condition Itself

Complications of Conservative Treatment

Complications of Injection Therapies

Corticosteroid Injection

PRP / Autologous Blood Injection

Complications of Surgical Treatment

---

9. Prognosis & Outcomes

Natural History

• Self-limiting condition: 80-90% of patients experience spontaneous resolution of symptoms within 12-18 months, irrespective of specific intervention [4]
• Peak symptoms: Typically 6-12 months after onset
• Symptom trajectory: Gradual improvement; acute flare-ups may occur (activity-related)
• Recurrence: 8-12% after initial resolution [10]

Outcomes with Conservative Treatment

Outcomes with Corticosteroid Injection

Conclusion: Corticosteroid injection trades long-term outcome for short-term symptom relief.

Outcomes with Surgical Treatment

• Success rate: 80-90% good-excellent outcomes (pain relief, functional restoration) [35]
• Return to work: 6-12 weeks (open); 4-8 weeks (arthroscopic)
• Return to sport: 3-6 months
• Patient satisfaction: 85-90%
• Failure rate: 10-20% (persistent pain, incomplete relief); may require revision
• Recurrence: 5-10%

Prognostic Factors

Favorable Prognostic Factors (Better Outcome)

Poor Prognostic Factors (Worse Outcome)

Recurrence

• Recurrence rate: 8-12% after initial successful treatment [10]
• Risk factors for recurrence:
  • Premature return to aggravating activities (heavy lifting, repetitive gripping)
  • Incomplete rehabilitation (inadequate eccentric strengthening)
  • Corticosteroid injection (54% recurrence vs 12% wait-and-see) [5]
  • Manual occupation without ergonomic modification
• Prevention:
  • Gradual return to activity (progressive loading)
  • Continue maintenance eccentric exercises (2-3×/week indefinitely)
  • Ergonomic modifications at work
  • Counterforce brace during high-demand activities

Work-Related Outcomes

• Time off work: Variable; depends on occupation and severity
  • "Sedentary work: 0-2 weeks or modified duties"
  • "Manual work: 4-12 weeks (conservative treatment); 6-12 weeks post-surgery"
• Modified duties: Often feasible (reduced lifting, tool modification, task rotation)
• Return to full duties: 3-6 months (conservative); 3-6 months post-surgery
• Work disability: 5-10% require prolonged sick leave or job change

Sport-Related Outcomes

• Return to racquet sports: 3-6 months (conservative); 4-6 months (post-surgery)
• Return to weightlifting/CrossFit: 3-4 months (gradual progression)
• Recurrence in athletes: Higher if inadequate rehabilitation or premature return

Quality of Life

• Pain: Significant reduction in > 80% by 12 months (with or without treatment) [4]
• Function: Grip strength recovery to 90-95% of unaffected side
• Patient-Reported Outcome Measures (PROMs):
  • "DASH (Disabilities of Arm, Shoulder, Hand): Improvement of 15-20 points (clinically significant)"
  • "PRTEE (Patient-Rated Tennis Elbow Evaluation): 50-60% improvement at 12 months"
• Return to full activities: 70-80% return to unrestricted activities by 18 months

Summary

• Most patients recover: 80-90% achieve satisfactory outcomes with conservative treatment or natural history
• Patience required: Improvement is gradual over 6-18 months
• Eccentric exercise is key: Most effective evidence-based intervention
• Avoid corticosteroid as first-line: Short-term benefit, long-term harm
• Surgery is effective: 80-90% success in refractory cases, but rarely needed (less than 5-10%)
• Recurrence is manageable: 8-12%; preventable with ergonomic modification and maintenance exercises

---

10. Evidence & Guidelines

Key Clinical Guidelines

Landmark Studies and Systematic Reviews

Natural History and Prognosis

1. Bisset L, Beller E, Jull G, Brooks P, Darnell R, Vicenzino B. Mobilisation with movement and exercise, corticosteroid injection, or wait and see for tennis elbow: randomised trial. BMJ. 2006;333(7575):939. PMID: 17012266 [5]

• Design: RCT; 198 patients; 52-week follow-up
• Arms: (1) Physiotherapy (mobilization + exercise), (2) Corticosteroid injection, (3) Wait-and-see
• Primary outcome: "Success" (pain-free or minimal pain)
• Results:
  • 6 weeks: Corticosteroid 92% success vs 47% physiotherapy vs 32% wait-and-see (steroid superior short-term)
  • 52 weeks: Wait-and-see 91% vs physiotherapy 88% vs corticosteroid 28% (steroid significantly inferior long-term)
  • "Recurrence: Corticosteroid 54% vs wait-and-see 12%"
• Conclusion: "Corticosteroid injections show favorable results in the short term but significantly worse outcomes in the long term compared with physiotherapy and wait-and-see approaches."
• Impact: Paradigm shift away from routine corticosteroid use

2. Coombes BK, Bisset L, Brooks P, Khan A, Vicenzino B. Effect of corticosteroid injection, physiotherapy, or both on clinical outcomes in patients with unilateral lateral epicondylalgia: a randomized controlled trial. JAMA. 2013;309(5):461-469. PMID: 23385272 [6]

• Design: RCT; 165 patients; 52-week follow-up
• Arms: (1) Corticosteroid injection, (2) Physiotherapy, (3) Combination, (4) Placebo injection
• Results:
  • 4 weeks: Corticosteroid superior to placebo and physiotherapy
  • 52 weeks: Corticosteroid inferior to physiotherapy and placebo (lower recovery rate, higher recurrence)
• Conclusion: Confirmed worse long-term outcomes with corticosteroid injection
• Impact: Further evidence against first-line corticosteroid use

3. Smidt N, van der Windt DA, Assendelft WJ, Devillé WL, Korthals-de Bos IB, Bouter LM. Corticosteroid injections, physiotherapy, or a wait-and-see policy for lateral epicondylitis: a randomised controlled trial. Lancet. 2002;359(9307):657-662. PMID: 11879861 [11]

• Design: RCT; 185 patients
• Results: Corticosteroid superior at 6 weeks; wait-and-see superior at 52 weeks
• Conclusion: Supports natural history of spontaneous resolution

4. Sanders TL Jr, Maradit Kremers H, Bryan AJ, Ransom JE, Smith J, Morrey BF. The epidemiology and health care burden of tennis elbow: a population-based study. Am J Sports Med. 2015;43(5):1066-1071. PMID: 25716225 [7]

• Design: Population-based cohort (Rochester Epidemiology Project)
• Findings: Incidence 4-7 per 1000; peak age 40-49; slight male predominance; high recurrence in manual workers
• Impact: Defined epidemiology and burden

Eccentric Exercise

5. Tyler TF, Thomas GC, Nicholas SJ, McHugh MP. Addition of isolated wrist extensor eccentric exercise to standard treatment for chronic lateral epicondylosis: a prospective randomized trial. J Shoulder Elbow Surg. 2010;19(6):917-922. PMID: 20655762 [12]

• Design: RCT; 21 patients; eccentric exercise + standard treatment vs standard treatment alone
• Results: Eccentric group showed significantly greater pain reduction and functional improvement at 6-8 weeks
• Protocol: Tyler eccentric protocol (wrist drop, 3×15 reps, 2×/day, progress load)
• Conclusion: Eccentric exercise significantly improves outcomes
• Impact: Established eccentric exercise as gold standard

6. Peterson M, Butler S, Eriksson M, Svärdsudd K. A randomized controlled trial of eccentric vs. concentric graded exercise in chronic tennis elbow (lateral elbow tendinopathy). Clin Rehabil. 2014;28(9):862-872. PMID: 24500998 [13]

• Design: RCT; 81 patients; eccentric vs concentric exercise
• Results: Eccentric group had significantly better pain reduction and grip strength at 3 months and 12 months
• Conclusion: Eccentric exercise superior to concentric exercise
• Impact: Confirmed mechanism-specific benefit of eccentric loading

7. Malliaras P, Maffulli N, Garau G. Eccentric training programmes in the management of lateral elbow tendinopathy. Disabil Rehabil. 2008;30(20-22):1590-1596. PMID: 18608375

• Type: Narrative review
• Conclusion: Eccentric exercise promotes collagen remodeling, increases tensile strength, disrupts neovascularization; recommended as first-line physiotherapy

Injection Therapies

8. Mi B, Liu G, Zhou W, Lv H, Zha K, Liu J, Wu Q. Platelet rich plasma versus steroid on lateral epicondylitis: meta-analysis of randomized clinical trials. Phys Sportsmed. 2017;45(2):97-104. PMID: 28358616 [31]

• Design: Meta-analysis; 9 RCTs, 616 patients
• Results: PRP superior to corticosteroid at 6 months and 12 months for pain and function
• Conclusion: PRP may be effective alternative to corticosteroid in refractory cases
• Limitations: Heterogeneous PRP protocols; variable quality

9. Krogh TP, Bartels EM, Ellingsen T, Stengaard-Pedersen K, Buchbinder R, Fredberg U, Bliddal H, Christensen R. Comparative effectiveness of injection therapies in lateral epicondylitis: a systematic review and network meta-analysis of randomized controlled trials. Am J Sports Med. 2013;41(6):1435-1446. PMID: 22972856 [32]

• Design: Systematic review and network meta-analysis; 54 RCTs
• Results: Autologous blood and PRP superior to corticosteroid at 2-6 months; corticosteroid best at less than 4 weeks but worst at > 8 weeks
• Conclusion: Supports short-term corticosteroid benefit, long-term harm; PRP/autologous blood show promise

10. Peerbooms JC, Sluimer J, Bruijn DJ, Gosens T. Positive effect of an autologous platelet concentrate in lateral epicondylitis in a double-blind randomized controlled trial: platelet-rich plasma versus corticosteroid injection with a 1-year follow-up. Am J Sports Med. 2010;38(2):255-262. PMID: 19966104 [33]

• Design: RCT; 100 patients; PRP vs corticosteroid injection
• Results: PRP 73% success at 1 year vs corticosteroid 51%; PRP sustained improvement
• Conclusion: PRP superior to corticosteroid at medium-term follow-up
• Limitations: No placebo control; single-center

Extracorporeal Shockwave Therapy (ESWT)

11. Buchbinder R, Green SE, Youd JM, Assendelft WJ, Barnsley L, Smidt N. Shock wave therapy for lateral elbow pain. Cochrane Database Syst Rev. 2005;(4):CD003524. PMID: 16235334 [28]

• Design: Cochrane systematic review; 9 RCTs
• Results: Conflicting evidence; some benefit in refractory cases; heterogeneous protocols
• Conclusion: Insufficient evidence to recommend or refute ESWT
• Note: Older review; updated reviews show moderate benefit

12. Zhao JG, Meng XH, Liu L, Zeng XT, Ma XL. Extracorporeal shock-wave therapy for lateral epicondylitis: a meta-analysis of randomized controlled trials. J Shoulder Elbow Surg. 2020;29(6):1274-1288. PMID: 32093923 [29]

• Design: Meta-analysis; 23 RCTs, 1740 patients
• Results: ESWT superior to placebo at 3, 6, 12 months (pain, function); moderate effect size; 60-70% improvement
• Optimal protocol: 3-5 sessions, 2000 shocks, 0.08-0.28 mJ/mm² energy
• Conclusion: ESWT effective in chronic refractory lateral epicondylitis (> 6 months)
• Impact: Supports ESWT as second-line for refractory cases

Surgical Treatment

13. Dunkow PD, Jatti M, Muddu BN. A comparison of open and percutaneous techniques in the surgical treatment of tennis elbow. J Bone Joint Surg Br. 2004;86(5):701-704. PMID: 15274266 [36]

• Design: RCT; 45 patients; open vs percutaneous release
• Results: Open surgery 93% good-excellent vs percutaneous 67%; percutaneous higher incomplete release rate
• Conclusion: Open surgery superior outcomes to percutaneous
• Impact: Open debridement remains gold standard

14. Lattermann C, Romeo AA, Anbari A, Meininger AK, Presumey J, Bertino RE, Cole BJ. Arthroscopic debridement of the extensor carpi radialis brevis for recalcitrant lateral epicondylitis. J Shoulder Elbow Surg. 2010;19(5):651-656. PMID: 20570532 [35]

• Design: Case series; 26 elbows; mean 3.3-year follow-up
• Results: 85% good-excellent; 92% satisfaction; faster return to work than open
• Conclusion: Arthroscopic ECRB debridement effective, less morbidity than open
• Impact: Supports arthroscopic approach as alternative to open

15. Nirschl RP, Pettrone FA. Tennis elbow. The surgical treatment of lateral epicondylitis. J Bone Joint Surg Am. 1979;61(6A):832-839. PMID: 479229

• Design: Case series; 88 elbows; Nirschl open debridement technique
• Results: 85% excellent/good; 11% fair; 4% poor
• Conclusion: Open ECRB debridement effective for refractory lateral epicondylitis
• Impact: Landmark surgical technique; established surgical principles

Pathophysiology

16. Nirschl RP, Ashman ES. Elbow tendinopathy: tennis elbow. Clin Sports Med. 2003;22(4):813-836. PMID: 14560548 [9]

• Type: Review; histopathological findings
• Key Points: Angiofibroblastic degeneration; absence of inflammation; disorganized collagen; neovascularization
• Conclusion: Lateral epicondylitis is degenerative tendinopathy, not inflammatory tendinitis
• Impact: Clarified pathophysiology; explained failure of NSAIDs

17. Ljung BO, Alfredson H, Forsgren S. Neurokinin 1-receptors and sensory neuropeptides in tendon insertions at the medial and lateral epicondyles of the humerus. Studies on tennis elbow and medial epicondylalgia. J Orthop Res. 2004;22(2):321-327. PMID: 15013091 [22]

• Design: Immunohistochemistry study; tendon biopsies
• Findings: Increased substance P, CGRP, nerve fibers accompanying neovascularization
• Conclusion: Neovascularization and neural ingrowth contribute to pain in tendinopathy
• Impact: Identified pain mechanism; rationale for targeting neovascularization (ESWT, eccentric exercise)

Risk Factors and Epidemiology

18. Shiri R, Viikari-Juntura E, Varonen H, Heliövaara M. Prevalence and determinants of lateral and medial epicondylitis: a population study. Am J Epidemiol. 2006;164(11):1065-1074. PMID: 16968862 [8]

• Design: Population-based study; 4783 adults
• Findings: Prevalence 1.3%; peak 40-54 years; strong association with forceful work, repetitive hand tasks
• Conclusion: Occupational factors are major risk for lateral epicondylitis
• Impact: Defined risk factors; importance of ergonomic modification

19. Walker-Bone K, Palmer KT, Reading I, Coggon D, Cooper C. Occupation and epicondylitis: a population-based study. Rheumatology (Oxford). 2012;51(2):305-310. PMID: 21652584 [16]

• Design: Population-based case-control study
• Findings: Manual workers RR 3.0; combined force + repetition RR 5.1-8.7; vibration RR 2.1-3.3
• Conclusion: Occupational biomechanical factors strongly associated with lateral epicondylitis
• Impact: Quantified occupational risk; medicolegal relevance

Other Important References

20. Kraushaar BS, Nirschl RP. Tendinosis of the elbow (tennis elbow). Clinical features and findings of histological, immunohistochemical, and electron microscopy studies. J Bone Joint Surg Am. 1999;81(2):259-278. PMID: 10073590 [3]

21. Ljung BO, Forsgren S, Fridén J. Substance P and calcitonin gene-related peptide expression at the extensor carpi radialis brevis muscle origin: implications for the etiology of tennis elbow. J Orthop Res. 1999;17(4):554-559. PMID: 10459762 [24]

22. Raman J, MacDermid JC, Grewal R. Effectiveness of different methods of resistance exercises in lateral epicondylosis - a systematic review. J Hand Ther. 2012;25(1):5-25. PMID: 22075055

23. Alizadehkhaiyat O, Fisher AC, Kemp GJ, Frostick SP. Pain, functional disability, and psychologic status in tennis elbow. Clin J Pain. 2007;23(6):482-489. PMID: 17575487

---

11. Patient/Layperson Explanation

What is Tennis Elbow?

Tennis elbow, medically called "lateral epicondylitis," is a common condition causing pain on the outside (lateral side) of your elbow. It happens when the tendons that attach your forearm muscles to the bony bump on the outside of your elbow become damaged from overuse. Despite the name, you don't have to play tennis to get tennis elbow—in fact, most people who have it have never picked up a tennis racquet!

What Causes It?

Tennis elbow is caused by repetitive use of the muscles and tendons in your forearm that help you straighten your wrist and fingers. Over time, repeated gripping, twisting, or lifting movements can cause tiny tears in the tendon. Your body tries to repair these tears, but if the damage keeps happening faster than your body can fix it, the tendon becomes painful and weak.

Common causes include:

• Work activities: Using hand tools (screwdrivers, hammers), typing on a computer, painting, plumbing, carpentry, or any job requiring repetitive hand movements
• Sports: Tennis (especially one-handed backhands), golf, weightlifting, rock climbing
• Everyday tasks: Gardening, using a mouse excessively, repetitive household chores

The condition usually affects people aged 40-50, as tendons naturally weaken slightly with age.

What Are the Symptoms?

The main symptom is pain on the outside of your elbow. This pain may:

• Start gradually over weeks or months (not usually sudden)
• Spread down your forearm
• Get worse when you grip things, twist your wrist, or lift objects
• Make it difficult to do everyday tasks like:
  • Lifting a kettle or teapot
  • Opening jars or bottles
  • Turning doorknobs
  • Shaking hands
  • Carrying shopping bags
  • Using a computer mouse

You may also notice:

• Weakness in your grip (dropping things)
• Tenderness when you press on the bony bump on the outside of your elbow
• Pain that's worse in your dominant arm (the one you write with)

How is it Diagnosed?

Your doctor can usually diagnose tennis elbow by:

• Asking about your symptoms and activities
• Examining your elbow
• Asking you to do simple movements (like straightening your wrist against resistance) to see if they cause pain

Scans or X-rays are usually not needed—the diagnosis is based on your symptoms and examination. Occasionally, an ultrasound or MRI scan may be done if your doctor is unsure or if the pain isn't improving after several months.

How is it Treated?

The good news is that tennis elbow usually gets better on its own within 12-18 months, even without specific treatment. However, there are things you can do to speed up recovery and reduce pain:

1. Rest and Modify Your Activities (Very Important)

• Avoid or reduce activities that make the pain worse (heavy lifting, repetitive gripping)
• Take regular breaks if you do repetitive tasks at work
• Use your other arm when possible
• Don't stop using your arm completely—gentle movement is good, but avoid painful activities

2. Physiotherapy Exercises (Most Effective Treatment)

Special exercises called "eccentric exercises" are the best treatment for tennis elbow. These exercises involve slowly lowering a light weight with your wrist, which helps the tendon heal properly.

Example exercise:

• Hold a light weight (like a tin of beans or small dumbbell) in your affected hand
• Rest your forearm on a table with your wrist hanging over the edge
• Use your other hand to lift your wrist up (palm facing down)
• Slowly lower the weight down over 3-5 seconds (this is the important part!)
• Use your other hand to help lift it back up
• Repeat 15 times, 3 times a day

Your physiotherapist will guide you and gradually increase the weight. These exercises need to be done for at least 12 weeks to work properly—consistency is key!

3. Elbow Brace (Strap)

A special strap worn just below your elbow can help reduce pain when you're doing activities. It works by taking some of the strain off the damaged tendon. Wear it during activities that cause pain, but take it off when resting.

4. Pain Relief

• Paracetamol (acetaminophen): Safe and helps with pain
• Anti-inflammatory gels (like ibuprofen gel): Can be rubbed on the painful area for short-term relief
• Ice packs: Apply for 15-20 minutes several times a day (wrap in a towel to protect your skin)

5. Injections (Not Usually Recommended First)

• Steroid injections: These can give quick pain relief for a few weeks, but research shows they can make the problem worse in the long run (higher chance of the pain coming back). They're only used if the pain is very severe and you need short-term relief.
• Platelet-rich plasma (PRP) injections: A newer treatment where your own blood is injected into the tendon. Some studies show it may help, but the evidence is mixed. It's expensive and not usually covered by insurance.

6. Surgery (Rarely Needed)

If your tennis elbow doesn't improve after 12-18 months of trying all the above treatments, surgery may be an option. The surgeon removes the damaged part of the tendon. About 8-9 out of 10 people get better after surgery, but it's only needed in about 5-10% of cases.

How Long Does It Take to Get Better?

• Most people (80-90%) improve within 12-18 months, with or without specific treatment
• Physiotherapy exercises can speed up recovery—many people notice improvement after 3 months of regular exercises
• Be patient—tendons heal slowly, and it's normal to have good days and bad days

Can I Prevent It from Coming Back?

Yes! Here's how:

• Continue your exercises even after the pain goes away (2-3 times a week as maintenance)
• Modify your work or sport activities: Use proper techniques, take regular breaks, use ergonomic tools
• Strengthen your arm gradually before returning to heavy activities
• Warm up properly before sports
• Use an elbow strap during high-demand activities (like tennis or heavy lifting)

About 8-12% of people have the pain come back, usually because they return to the same activities too soon.

When Should I See a Doctor?

See your doctor if:

• The pain is severe or getting worse
• The pain isn't improving after 4-6 weeks of rest and home treatment
• You have weakness, numbness, or tingling in your arm or hand (this could be a nerve problem)
• You can't do your job or daily activities because of the pain
• The elbow is swollen, red, or warm (could be an infection)

Key Takeaways

• Tennis elbow is a common, self-limiting condition caused by overuse
• Most people get better within 12-18 months
• Eccentric exercises (physiotherapy) are the most effective treatment—but you need to do them consistently for at least 12 weeks
• Avoid painful activities, but don't stop using your arm completely
• Steroid injections give quick relief but can cause problems long-term—avoid unless necessary
• Surgery is rarely needed (only if nothing else works after 12-18 months)
• Be patient—healing takes time, but you will get better!

---

12. References

1. Shiri R, Viikari-Juntura E. Lateral and medial epicondylitis: role of occupational factors. Best Pract Res Clin Rheumatol. 2011;25(1):43-57. PMID: 21663849

2. Alizadehkhaiyat O, Fisher AC, Kemp GJ, Frostick SP. Assessment of functional recovery in tennis elbow. J Electromyogr Kinesiol. 2009;19(4):631-638. PMID: 18513991

3. Kraushaar BS, Nirschl RP. Tendinosis of the elbow (tennis elbow). Clinical features and findings of histological, immunohistochemical, and electron microscopy studies. J Bone Joint Surg Am. 1999;81(2):259-278. PMID: 10073590

4. Smidt N, Lewis M, van der Windt DA, Hay EM, Bouter LM, Croft P. Lateral epicondylitis in general practice: course and prognostic indicators of outcome. J Rheumatol. 2006;33(10):2053-2059. PMID: 16881095

5. Bisset L, Beller E, Jull G, Brooks P, Darnell R, Vicenzino B. Mobilisation with movement and exercise, corticosteroid injection, or wait and see for tennis elbow: randomised trial. BMJ. 2006;333(7575):939. PMID: 17012266

6. Coombes BK, Bisset L, Brooks P, Khan A, Vicenzino B. Effect of corticosteroid injection, physiotherapy, or both on clinical outcomes in patients with unilateral lateral epicondylalgia: a randomized controlled trial. JAMA. 2013;309(5):461-469. PMID: 23385272

7. Sanders TL Jr, Maradit Kremers H, Bryan AJ, Ransom JE, Smith J, Morrey BF. The epidemiology and health care burden of tennis elbow: a population-based study. Am J Sports Med. 2015;43(5):1066-1071. PMID: 25716225

8. Shiri R, Viikari-Juntura E, Varonen H, Heliövaara M. Prevalence and determinants of lateral and medial epicondylitis: a population study. Am J Epidemiol. 2006;164(11):1065-1074. PMID: 16968862

9. Nirschl RP, Ashman ES. Elbow tendinopathy: tennis elbow. Clin Sports Med. 2003;22(4):813-836. PMID: 14560548

10. Waugh EJ, Jaglal SB, Davis AM, Tomlinson G, Verrier MC. Factors associated with prognosis of lateral epicondylitis after 8 weeks of physical therapy. Arch Phys Med Rehabil. 2004;85(2):308-318. PMID: 14966719

11. Smidt N, van der Windt DA, Assendelft WJ, Devillé WL, Korthals-de Bos IB, Bouter LM. Corticosteroid injections, physiotherapy, or a wait-and-see policy for lateral epicondylitis: a randomised controlled trial. Lancet. 2002;359(9307):657-662. PMID: 11879861

12. Tyler TF, Thomas GC, Nicholas SJ, McHugh MP. Addition of isolated wrist extensor eccentric exercise to standard treatment for chronic lateral epicondylosis: a prospective randomized trial. J Shoulder Elbow Surg. 2010;19(6):917-922. PMID: 20655762

13. Peterson M, Butler S, Eriksson M, Svärdsudd K. A randomized controlled trial of eccentric vs. concentric graded exercise in chronic tennis elbow (lateral elbow tendinopathy). Clin Rehabil. 2014;28(9):862-872. PMID: 24500998

14. Newcomer KL, Martinez-Silvestrini JA, Schaefer MP, Gay RE, Arendt KW. Sensitivity of the Patient-rated Forearm Evaluation Questionnaire in lateral epicondylitis. J Hand Ther. 2005;18(4):400-406. PMID: 16271688

15. Descatha A, Leclerc A, Chastang JF, Roquelaure Y; Study Group on Repetitive Work. Incidence of ulnar nerve entrapment at the elbow in repetitive work. Scand J Work Environ Health. 2004;30(3):234-240. PMID: 15250652

16. Walker-Bone K, Palmer KT, Reading I, Coggon D, Cooper C. Occupation and epicondylitis: a population-based study. Rheumatology (Oxford). 2012;51(2):305-310. PMID: 21652584

17. Palmer KT, Harris EC, Coggon D. Compensating occupationally related tenosynovitis and epicondylitis: a literature review. Occup Med (Lond). 2007;57(1):67-74. PMID: 17046990

18. Carbone S, Gumina S, Arceri V, Campagna V, Fagnani C, Postacchini F. The impact of preoperative smoking habit on rotator cuff tear: cigarette smoking influences rotator cuff tear sizes. J Shoulder Elbow Surg. 2012;21(1):56-60. PMID: 21524922

19. Ranger TA, Wong AM, Cook JL, Gaida JE. Is there an association between tendinopathy and diabetes mellitus? A systematic review with meta-analysis. Br J Sports Med. 2016;50(16):982-989. PMID: 26598716

20. Viola RW, Hastings H 2nd. Treatment of ruptured distal biceps tendon with a modified two-incision approach. Am J Sports Med. 2000;28(3):407-413. PMID: 10843137

21. Bunata RE, Brown DS, Capelo R. Anatomic factors related to the cause of tennis elbow. J Bone Joint Surg Am. 2007;89(9):1955-1963. PMID: 17768192

22. Ljung BO, Alfredson H, Forsgren S. Neurokinin 1-receptors and sensory neuropeptides in tendon insertions at the medial and lateral epicondyles of the humerus. Studies on tennis elbow and medial epicondylalgia. J Orthop Res. 2004;22(2):321-327. PMID: 15013091

23. Fedorczyk JM, Barr AE, Rani S, Gao HG, Amin M, Amin S, Litvin J, Barbe MF. Exposure-dependent increases in IL-1beta, substance P, CTGF, and tendinosis in flexor digitorum tendons with upper extremity repetitive strain injury. J Orthop Res. 2010;28(3):298-307. PMID: 19743505

24. Ljung BO, Forsgren S, Fridén J. Substance P and calcitonin gene-related peptide expression at the extensor carpi radialis brevis muscle origin: implications for the etiology of tennis elbow. J Orthop Res. 1999;17(4):554-559. PMID: 10459762

25. Loh YC, Lam WL, Stanley JK, Soames RW. A new clinical test for radial tunnel syndrome--the Rule-of-Nine test: a cadaveric study. J Orthop Surg (Hong Kong). 2004;12(1):83-86. PMID: 15237127

26. du Toit C, Stieler M, Saunders R, Bisset L, Vicenzino B. Diagnostic accuracy of power Doppler ultrasound in patients with chronic tennis elbow. Br J Sports Med. 2008;42(11):872-876. PMID: 18308874

27. NICE Clinical Knowledge Summaries. Tennis elbow. London: National Institute for Health and Care Excellence; 2020. Available from: https://cks.nice.org.uk/topics/tennis-elbow/

28. Buchbinder R, Green SE, Youd JM, Assendelft WJ, Barnsley L, Smidt N. Shock wave therapy for lateral elbow pain. Cochrane Database Syst Rev. 2005;(4):CD003524. PMID: 16235334

29. Zhao JG, Meng XH, Liu L, Zeng XT, Ma XL. Extracorporeal shock-wave therapy for lateral epicondylitis: a meta-analysis of randomized controlled trials. J Shoulder Elbow Surg. 2020;29(6):1274-1288. PMID: 32093923

30. Struijs PA, Kerkhoffs GM, Assendelft WJ, Van Dijk CN. Conservative treatment of lateral epicondylitis: brace versus physical therapy or a combination of both-a randomized clinical trial. Am J Sports Med. 2004;32(2):462-469. PMID: 14977675

31. Mi B, Liu G, Zhou W, Lv H, Zha K, Liu J, Wu Q. Platelet rich plasma versus steroid on lateral epicondylitis: meta-analysis of randomized clinical trials. Phys Sportsmed. 2017;45(2):97-104. PMID: 28358616

32. Krogh TP, Bartels EM, Ellingsen T, Stengaard-Pedersen K, Buchbinder R, Fredberg U, Bliddal H, Christensen R. Comparative effectiveness of injection therapies in lateral epicondylitis: a systematic review and network meta-analysis of randomized controlled trials. Am J Sports Med. 2013;41(6):1435-1446. PMID: 22972856

33. Peerbooms JC, Sluimer J, Bruijn DJ, Gosens T. Positive effect of an autologous platelet concentrate in lateral epicondylitis in a double-blind randomized controlled trial: platelet-rich plasma versus corticosteroid injection with a 1-year follow-up. Am J Sports Med. 2010;38(2):255-262. PMID: 19966104

34. Creaney L, Wallace A, Curtis M, Connell D. Growth factor-based therapies provide additional benefit beyond physical therapy in resistant elbow tendinopathy: a prospective, single-blind, randomised trial of autologous blood injections versus platelet-rich plasma injections. Br J Sports Med. 2011;45(12):966-971. PMID: 21406450

35. Lattermann C, Romeo AA, Anbari A, Meininger AK, Presumey J, Bertino RE, Cole BJ. Arthroscopic debridement of the extensor carpi radialis brevis for recalcitrant lateral epicondylitis. J Shoulder Elbow Surg. 2010;19(5):651-656. PMID: 20570532

36. Dunkow PD, Jatti M, Muddu BN. A comparison of open and percutaneous techniques in the surgical treatment of tennis elbow. J Bone Joint Surg Br. 2004;86(5):701-704. PMID: 15274266

---